跳至主要内容
临床试验/DRKS00027002
DRKS00027002尚未招募不适用

Determination of predictors of mental illness based on retrospective analyses of clinical and structural imaging data collected from patients during their inpatient stay at the LVR-Klinikum Düsseldorf - Kliniken der Heinrich-Heine-Universität Düsseldorf - retroStudy DUS

Klinik und Poliklinik für Psychiatrie und Psychotherapie, LVR-Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität Düsseldorf0 个研究点目标入组 3,000 人开始时间: 2021年11月2日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
3,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
14 Years 至 65 Years(—)
性别
All

入选标准

  • All patients with F20/F30 diagnoses who underwent a magnetic resonance imaging examination at LVR-Klinikum Düsseldorf between 1/1/2013 and 6/30/2021.

排除标准

  • - somatic causes of psychiatric disorders
  • - profound developmental disorder
  • - severe intelligence impairment
  • - age > 65years

研究者

发起方
Klinik und Poliklinik für Psychiatrie und Psychotherapie, LVR-Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität Düsseldorf

相似试验

招募中
不适用
Identifying Predictors of mental, functional, and medical outcome in Obesity SurgeryE66.92
DRKS00021132WL Universitätsklinik für Psychosomatik und Psychotherapie der Ruhr-Universität Bochum800
招募中
不适用
Quantifying Psychiatric Disorders with Natural Language Processing on Conversational Data1. Patients with major depressive disorder, bipolar I/II disorder, schizophrenia, anxiety disorders (or obsessive-compulsive disorder), and major/mild neurocognitive disorder by DSM-5 or ICD-10 2. Healthy volunteers
JPRN-UMIN000032141Keio University School of Medicine500
已完成
不适用
Quantifying Psychiatric Disorders with Natural Language Processing: A Pilot Study1. Patients with major depressive disorder, bipolar I/II disorder, schizophrenia, anxiety disorders, and major/mild neurocognitive disorder by DSM-5 2. Healthy volunteers
JPRN-UMIN000027080Keio University School of Medicine30
进行中(未招募)
1 期
EVALUATION OF POTENTIAL PREDICTORS OF DISEASE PROGRESSION IN PATIENTS WITH aHUS, INCLUDING GENETICS, BIOMARKERS, ANDTREATMENTatypical Hemolytic-Uremic Syndrome (aHUS)MedDRA version: 19.1Level: LLTClassification code 10019515Term: Hemolytic uremic syndromeSystem Organ Class: 100000004851
EUCTR2015-003135-35-DEAlexion Pharmaceuticals, Inc.330
进行中(未招募)
1 期
EVALUATION OF POTENTIAL PREDICTORS OF DISEASE PROGRESSION IN PATIENTS WITH aHUS, INCLUDING GENETICS, BIOMARKERS, AND TREATMENTatypical Hemolytic-Uremic Syndrome (aHUS)MedDRA version: 19.0Level: LLTClassification code 10019515Term: Hemolytic uremic syndromeSystem Organ Class: 100000004851
EUCTR2015-003135-35-BEAlexion Pharmaceuticals, Inc.330